期刊文献+

世界卫生组织急性白血病分型2016版与2008版区别 被引量:3

Difference between the Classification of Acute Leukemia by World Health Organization in 2016 and 2008 Editions
下载PDF
导出
摘要 时隔8年世界卫生组织(WHO)对急性白血病分型进行了修改,本文介绍了WHO急性白血病分型2016版与2008版的区别,结合细胞遗传学和预后等分析了2016版对2008版进行删除或增加的原因。WHO急性白血病分型2016版能更好地结合和指导临床。为了临床医生能及时掌握最新急性白血病分型,并积极为医学创新做准备,本文比较分析WHO急性白血病分型2016版与2008版的区别。 After eight years,the World Health Organization( WHO)has made amendments on the classification of acute leukemia. The differences between classification of acute leukemia by WHO in 2016 and 2008 editions are introduced in this paper. The reasons for deleting or adding contents in the 2016 edition based on the 2008 edition are analyzed in combination with cytogenetics and prognosis. The classification of acute leukemia by WHO in the 2016 edition can better combine and guide clinical practices. The differences between the classification of acute leukemia by WHO in the 2016 and 2008 editions are reviewed to help clinical doctors understand the latest types of acute leukemia and prepare for medical innovation.
出处 《中国全科医学》 CAS CSCD 北大核心 2016年第26期3253-3256,共4页 Chinese General Practice
关键词 白血病 世界卫生组织 分型 Leukemia World health organization Classification
  • 相关文献

参考文献23

  • 1CAMPO E, SWERDLOW S H, HARRIS N L, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications [J]. Blood, 2011, 117 (19) :5019 -5032.
  • 2ARBER D A, ORAZI A, HASSERJ1AN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J]. Blood, 2016, 127 (20) : 2391 -2405.
  • 3GROSCHEL S, SANDERS M A, HOOGENBOEZEM R, et al. A single oncogenic enhancer rearrangement causes concomitant EVIl and GATA2 deregulation in leukemia [J]. Cell, 2014, 157 (2) : 369 -381.
  • 4KONOPLEV S, YIN C C, KORNBLAU S M, et al. Molecular characterization of de novo philadelphia chromosome - positive acute myeloid leukemia [ J]. Leuk Lymphoma, 2013, 54 ( 1 ) : 138 - 144.
  • 5NACHEVA E P, GRACE C D, BRAZMA D, et al. Does BCR/ ABL1 positive acute myeloid leukaemia exist? [ J ]. Br J Haematol, 2013, 161 (4): 541-550.
  • 6MENDLER J H, MAHARR K, RADMACHER M D, et al. RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures [ J ]. J Clin Oncol, 2012, 30 (25): 3109-3118.
  • 7FALINI B, MACIJEWSKI K, WEISS T, et al. Muhilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin ( NPM1 ) [J]. Blood, 2010, 115 (18): 3776-3786.
  • 8BACHER U, SCHNITTGER S, MACIJEWSKI K, et al. Muhilineage dysplasia does not influence prognosis in CEBPA - mutated AML, supporting the WHO proposal to classify these patients as a unique entity [J]. Blood, 2012, 119 (20) : 4719 - 4722.
  • 9SCHLENK R F, TASKESEN E, VAN NORDEN Y, et al. The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA [J]. Blood, 2013, 122 (9) : 1576 -1582.
  • 10WALTER R B, OTHUS M, BURNETT A K, et al. Significance of FAB subclassification of " acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients [J]. Blood, 2013, 121 (13): 2424-2431.

同被引文献24

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部